Socio-demographic factors, dental status and health-related behaviors associated with geriatric oral health-related quality of life in Southwestern China

from Health and Quality of Life Outcomes at http://bit.ly/2IEcHvB on May 21, 2018 at 09:03PM The aging of Chinese society has increased interest in improving the health-related quality of life (HRQoL) of the elderly, including their oral health-related quality of life (OHRQoL). This study aims to evaluat…

The treatment of incomplete data: Reporting, analysis, reproducibility, and replicability

from Social Science & Medicine at http://bit.ly/2wV9BBU on May 21, 2018 at 04:12PM Publication date: Available online 21 May 2018 Source:Social Science & Medicine Author(s): Yulia Sidi, Ofer Harel Proper analysis and reporting of incomplete data continues to be a challenging task for practitioners from various research areas. Recently Nguyen, Strazdins, Nicholson and Cooklin (NSNC; […]

The moral significance of capturing micro-inequities in hospital settings

from Social Science & Medicine at http://bit.ly/2KGntSK on May 20, 2018 at 04:13PM Publication date: Available online 19 May 2018 Source:Social Science & Medicine Author(s): Supriya Subramani This paper illustrates and reflects on subtle micro-level events and practices that sustain and reproduce unequal relationships in healthcare encounters, and draws attention to their moral significance in […]

Discounting in Economic Evaluations

from PharmacoEconomics at http://bit.ly/2Is3SsN on May 19, 2018 at 05:15AM Abstract Appropriate discounting rules in economic evaluations have received considerable attention in the literature and in national guidelines for economic evaluations. Rightfully so, as discounting can be quite influential on the outcomes of economic evaluations. The most prominent controversies regarding discounting involve the basis for […]

Are PCSK9 Inhibitors Cost Effective?

from PharmacoEconomics at http://bit.ly/2KBNNgx on May 19, 2018 at 05:15AM Abstract The objective of this study was to review available health economic evaluations of PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors. These drugs reduce low-density lipid cholesterol levels and cardiovascular risk, but their cost effectiveness has been questioned. We searched Medline and Embase for economic […]